Trivalent vaccine (Baxter international)

百白破疫苗(百日咳/白喉/破伤风,百特国际)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTrivalent vaccine (Baxter international)
Drug Alias NameDTaP (Baxter international)Certiva-EUCertiva
ClassificationVaccines > Biological material > Toxoid vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTetanusDiphtheriaWhooping Cough
Global Approved IndicationsTetanusDiphtheriaWhooping Cough
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1998/07/29
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesBaxter International Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBaxter International Inc
Active IndicationsN/A
Inactive IndicationsTetanusDiphtheriaWhooping Cough

Other Information

ATC CodeJ07AJ52
Related LinksN/A